Literature DB >> 8642600

The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants.

U Johanson1, A Aevarsson, A Liljas, D Hughes.   

Abstract

We have previously identified 20 different fusidic acid-resistant alleles of fusA, encoding mutant forms of the ribosomal translocase EF-G. One of these, P413L, is used here as the starting point in selections for internal revertants, identifying 20 different pseudo-wild-type forms of EF-G. We have also identified two alleles of fusA previously isolated as suppressors of 4.5 S RNA deficiency. All of these mutants are analysed in terms of their effects on the structural dynamics of EF-G. Most mutation conferring fusidic acid-resistance interfere with conformational changes of EF-G, but some may be located at a possible fusidic acid binding site. Revertants of the P413L mutations restore the function of EF-G with or without affecting the level of resistance to fusidic acid. The revertant mutations probably restore the balance between the GDP and GTP conformations of EF-G off the ribosome, and most of them are located close to the interface between the G domain and domain II. The procedure for the isolation of pseudo-wild-type forms of EF-G can be used to direct evolution progressively away from the wild-type while still maintaining the essential functions of EF-G.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642600     DOI: 10.1006/jmbi.1996.0259

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

1.  Domain motions of EF-G bound to the 70S ribosome: insights from a hand-shaking between multi-resolution structures.

Authors:  W Wriggers; R K Agrawal; D L Drew; A McCammon; J Frank
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

2.  Conserved but nonessential interaction of SRP RNA with translation factor EF-G.

Authors:  Madi Bidya Sagar; Louise Lucast; Jennifer A Doudna
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

Review 3.  The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts.

Authors:  R Craig MacLean; Alex R Hall; Gabriel G Perron; Angus Buckling
Journal:  Nat Rev Genet       Date:  2010-06       Impact factor: 53.242

4.  Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.

Authors:  Wilhelm Paulander; Alexandra Pennhag; Dan I Andersson; Sophie Maisnier-Patin
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 5.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

Review 6.  Prediction of antibiotic resistance: time for a new preclinical paradigm?

Authors:  Morten O A Sommer; Christian Munck; Rasmus Vendler Toft-Kehler; Dan I Andersson
Journal:  Nat Rev Microbiol       Date:  2017-07-31       Impact factor: 60.633

7.  Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 8.  Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors:  Prabhavathi Fernandes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

9.  Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus.

Authors:  Jonas Lannergård; Tobias Norström; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

10.  Fusidic acid-resistant mutants of Salmonella enterica serovar Typhimurium with low fitness in vivo are defective in RpoS induction.

Authors:  Mirjana Macvanin; Johanna Björkman; Sofia Eriksson; Mikael Rhen; Dan I Andersson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.